ET-traps: A Potential Therapeutic for Use in Human Complications of the Heart and Kidneys

Endothelin-1 (ET-1) is a potent bioactive mediator that induces vasoconstriction and promotes vascular remodeling. Previous studies indicate ET-1 plays an important role in the pathophysiology of humans. This includes various cardiovascular renal complications. Some humans with chronic heart failure might also have failure. The organ damage kidneys increases age. While symptoms will vary according to affected organ, patient likely need special management, including restricted diet and/or therapeutic. ET-traps, patented technology, are novel molecular construct, which has been shown significantly sequester increased levels found different disease states. ET-traps be potential therapeutic for ameliorating pathologies related elevate levels, such as disruptions kidney functions. Hence, could effectively tackle serious health conditions associated endothelin system. paper discusses application use human complications kidneys.